@article{d0b3200d6485428d914c74bb989c763f,
title = "Does remote monitoring change OSA management and CPAP adherence?",
abstract = "It is increasingly recognized that the high prevalence of obstructive sleep apnoea (OSA), and its associated cardio-metabolic morbidities make OSA a burden for society. Continuous positive airway pressure (CPAP), the gold standard treatment, needs to be used for more than 4 h/night to be effective, but suffers from relatively poor adherence. Furthermore, CPAP is likely to be more effective if combined with lifestyle changes. Thus, the remote telemonitoring (TM) of OSA patients in terms of CPAP use, signalling of device problems, following disease progression, detection of acute events and monitoring of daily physical activity is an attractive option. In the present review, we aim to summarize the recent scientific data on remote TM of OSA patients, and whether it meets expectations. We also look at how patient education and follow-up via telemedicine is used to improve adherence and we discuss the influence of the profile of the healthcare provider. Then, we consider how TM might be extended to encompass the patient's cardio-metabolic health in general. Lastly, we explore how TM and the deluge of data it potentially generates could be combined with electronic health records in providing personalized care and multi-disease management to OSA patients.",
keywords = "co-morbidities, e-health, home remote monitoring, integrated care, sleep apnoea",
author = "P{\'e}pin, {Jean L.} and Renaud Tamisier and Dennis Hwang and Suresh Mereddy and Sairam Parthasarathy",
note = "Funding Information: Professor P{\'e}pin reports grants or research support from Resmed, Philips, Fisher and Paykel, Agiradom, Astra Zeneca, Mutualia, Vitalaire, Air Liquide Foundation; and honoraria or consultation fees from Resmed, Philips, Agiradom, Astra Zeneca, Bohringer. Dr. Parthasarathy reports grants from NIH/NHLBI (HL095799), grants from Patient Centered Outcomes Research Institute (IHS-1306-2505, EAIN #3394-UoA and PPRND-1507-31666), grants from US Department of Defense, grants from NIH (National Cancer Institute; R21CA184920), grants from Johrei Institute, personal fees from American Academy of Sleep Medicine, personal fees from American College of Chest Physicians, non-financial support from National Center for Sleep Disorders Research of the NIH (NHLBI), personal fees from UpToDate Inc., Philips-Respironics, Inc., Merck, Inc. and Vapotherm, Inc.; grants from Younes Sleep Technologies, Ltd., Niveus Medical Inc. and Philips-Respironics, Inc. outside the submitted work. In addition, Dr. Parthasarathy has a patent UA 14–018 U.S.S.N. 61/884,654; PTAS 502570970 (Home breathing device). The above-mentioned conflicts including the patent are unrelated to the topic of this paper. The other authors have no conflicts to disclose. Funding Information: We thank Alison Foote (Grenoble Alps University Hospital) for critically editing the manuscript. This work was funded by National Institutes of Health/National Heart, Lung and Blood Institute (HL095799), grants from Patient Centered Outcomes Research Institute (IHS-1306-2505, EAIN #3394-UoA, and PPRND-1507-31666) and Endowment fund {\textquoteleft}AGIR pour les maladies chroniques{\textquoteright}. This work was also supported by the French National Research Agency in the framework of the {\textquoteleft}Investisse-ments d{\textquoteright}avenir{\textquoteright} program (ANR-15-IDEX-02). Publisher Copyright: {\textcopyright} 2017 Asian Pacific Society of Respirology",
year = "2017",
month = nov,
doi = "10.1111/resp.13183",
language = "English (US)",
volume = "22",
pages = "1508--1517",
journal = "Respirology",
issn = "1323-7799",
publisher = "John Wiley and Sons Inc.",
number = "8",
}